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ABSTRACT 
 
 
 Lipopolysaccharide (LPS), or endotoxin, is the major component of the outer 
surface of gram-negative bacteria. LPS is a potent
 
activator of cells of the immune and 
inflammatory systems, including
 
macrophages, monocytes, and endothelial cells, and 
contributes
 
to systemic changes known as septic shock.  Each LPS molecule has three 
regions: oligosaccharide, core, and lipid A.  Oligosaccharide is exposed on the cell 
surface, and lipid A anchors LPS in the outer membrane. Recent studies from our lab 
demonstrated that LPS of periodontal pathogens suppresses neutrophil’s ability to secrete 
super oxide ions and also shown it to interfere with neutrophil chemotaxis. These factors 
are believed to aid the pathogens to remain “stealthy” and avoid killing by the 
mononuclear phagocyte cells. Secretory Leukocyte Protease Inhibitor (SLPI) is a single-
chain serine protease inhibitor secreted from secretary and inflammatory cells that 
protects tissue from damage caused by the inflammatory response. The present study 
examined the interaction of LPS prepared from periodontal pathogens with monocytes to 
stimulate them to secrete SLPI. The hypothesis of this study is that (1) LPS molecules of 
more pathogenic periodontal pathogens are better inducer of monocots to secrete SLPI, 
and (2) Secreted SLPI in turn inhibits the production of inflammatory cytokines produced 
by monocytes in response to LPS. The limited stimulation of monotypic cells to secrete 
super oxide ions as shown previously along with the proposed hypothesis that pathogenic 
organisms produces more SLPI to suppress the inflammatory cytokines may aid the 
pathogens to remain undetected by mononuclear phagocytes. 
  
The LPS from three different periodontal pathogens, Porphyromonas gingivalis, 
Prevotella denticola, and Fusobacterium nucleatum were isolated for this study under 
identical conditions. Cultured human monocytic cells were incubated with LPS and the 
amounts of SLPI secreted were measured. Monocytic cells were also incubated with 
endogenous SLPI along with LPS of the selected periodontal pathogens and the secretion 
of the cytokines IL-1  and TNF-  was measured by ELISA. 
  
The results demonstrated that LPS of periodontal pathogens differ in their ability 
to stimulate inflammatory cytokines. Pathogenic strains appear to induce secretion of 
greater amounts of cytokines than the less pathogenic organisms.  Pathogenic organisms 
tested also showed to induce the cultured THP-1 cells to secrete SLPI.  In the presence of 
exogenous SLPI, the amounts of inflammatory cytokines secreted by THP cells when 
stimulated with LPS appeared to be diminished.   
  
 The long-term objective is to understand the mechanisms, by which the 
periodontal pathogens escape detection by human defensive cells, colonize the gingival 
tissue and cause severe periodontitis. Understanding the evasive mechanisms by which 
pathogenic microorganisms escape detection or stimulate the host cells to secrete 
proteins, such as SLPI, which suppresses production of inflammatory cytokines, may aid 
the pathogenic organisms to survive in the oral cavity and continue their pathogenic 
effects.  
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW 
 
 
Periodontal Pathogens and Periodontal Disease 
  
Periodontal disease is a chronic polymicrobial infection caused mainly by gram-
negative, motile, strictly anaerobic microorganisms that leads to the destruction of tooth 
supporting tissue using a variety of immunopathogenic mechanisms.  The gingival sulcus 
hosts a complex microbial ecosystem.  At this time over 500 different species of bacteria 
in the oral cavity have been identified although only few are known to be associated with 
periodontal disease, among these are Porphyromonas gingivalis, Tannerella forsythia, 
and Fusobacterium nucleatum (1,2).  Tissue damage in the oral cavity was associated 
with the presence of these organisms through the production of various virulence factors 
including:  fimbriae, capsule and endotoxin, and through deregulation of the host’s innate 
and acquired immunity systems (3).  It has been shown that different combinations of 
indigenous bacteria have the potential to cause progression from gingivitis to 
periodontitis.  Slots (4) studied adults with advanced periodontitis and reported 
Aggregatibacter actinomycetemcomitans (Aa) in 50% of progressing lesions but in only 
6% of non-progressing lesions.  P. gingivalis was seen in 42% to 52% of progressing 
lesions and from 14% of non-progressing sites.  P. intermedia was found in 59% to 89% 
of progressing lesions and from 36% to 53% of non-progressing sites (4).  
  
Periodontitis progresses due to the interaction between the pathogenetic bacteria’s 
production of endotoxin and the host immune cells.  These interactions will lead to an 
immune response, which will result in the production of various cytokines, such as 
Interleukin-1-alpha (IL-1 Interleukin-1-Beta (IL-1 , Interleukin-6 (IL-6), and Tumor 
Necrosis Factor-alpha (TNF- , which dictate the rate and progression of periodontal 
tissue destruction by activating an inflammatory reaction (5-7).  Endotoxin allows the 
bacteria to colonize subgingivally, resist the immune system, and cause tissue destruction 
(8).  The LPS from gram-negative organisms such as Aa and P. gingivalis were shown to 
stimulate inflammatory cells like polymorphonuclear leukocytes (PMNs) to release 
several cytokines including IL-1α, IL-1β and TNF-α.  It has been shown that IL-1α and 
TNF-α can activate osteoclastic bone resorption indirectly by stimulating stromal cells 
(9,10).  IL-1β was originally named osteoclast-activating factor because of its resorptive 
properties in bone cell cultures (11).  In addition, the LPS of different gram-negative 
bacteria have been shown to stimulate bone resorption in an organ culture system (10).  
For example, P. intermedia LPS plays a major role in the peripheral bone resorption 
process mediated by prostaglandin E2 (PGE2) (12).  Increased permeability and neutrophil 
infiltration has resulted from the LPS induced PGE2 production (13).  It has been 
advocated that PMNs actions result in local tissue injury by becoming hyperactive in 
response to bacterial infection and are primed for actions that result in tissue breakdown 
(14).   
 
TNF-α is a cytokine originally thought to play a role in host surveillance against 
neoplasms.  Endotoxin-stimulated macrophages are the most important source of TNF- .  
TNF-  was initially identified as a factor produced by leukocytes and was thought to be 
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responsible for infection-induced cachexia.  It has been recognized subsequently that 
TNF has a broader range of effects on host immune responsiveness, such as enhancing 
polymorphonuclear neutrophil-endothelial interactions and facilitating phagocytosis and 
bacterial killing.  Recently, a role for TNF in the generation of free radicals and the 
pathophysiological changes during sepsis and septic shock has been proposed (5).  
Monocytes are thought to play an important role in the immunopathogenesis of 
periodontal diseases.  They are attracted to an area of infection and differentiate into 
macrophages.  Some appear to be primarily phagocytic whereas some function as 
antigen-processing cells (14).  Monocytes also produce substances that are involved in 
perpetuation of inflammation and result in tissue destruction called cytokines.  Cytokines 
are intercellular signals that function to regulate cellular activity.  Monocytes produce 
 IL-1  and TNF-α cytokines that exert inflammatory effects on the injured target cells in 
the host (15).   
 
 
Lipopolysaccharide and Gram-Negative Bacteria 
  
 Lipopolysaccharides (LPS) is a major constituent of the outer membrane of   
gram-negative bacteria and are found in all gram-negative bacteria.  A typical bacterium 
has approximately three-and-one-half million LPS molecules (16).  The LPS molecule 
(Figure 1.1) consists of a covalently attached hydrophobic domain known as lipid A or 
endotoxin, a non-repeating core oligosaccharide, and a distal polysaccharide or              
O-antigenic side chain.  The most essential part is lipid A, a covalently linked component 
of LPS that anchors the LPS molecule in the bacterial outer membrane.  Lipid A is 
hydrophobic, glucosamine-based phospholipid that comprises the outer monolayer of the 
outer membranes of most Gram-negative bacteria (17).  The lipid A component generally 
consists of six or more fatty acid residues linked to two phosphorylated glucosamine 
sugars.  Four of these fatty acids carry a hydroxyl group on the third carbon, while the 
other two are not hydroxylated (18).  Lipid A is bound to the core through an 8-carbon 
sugar, 2-keto-3-deoxyoctonate (KDO) lipid A linkage.  The core can be divided into an 
inner core and an outer core.  The inner core, which consists of two or more                    
2-keto-3-deoxyoctonic acid (KDO) sugars linked to the lipid A glucosamine and two or 
three heptose (L-glycero-D-manno-heptose) sugars linked to the KDO. The outer core 
consists of common sugars and is more variable than the inner core. It normally consists 
of L-glycero-D-manno-heptose or D-glycero-L-mannoheptose and a variety of hexoses 
(19,20).  The core is attached to the O-antigen via glycoside linkage.  The O-antigen is 
highly immunogenic and is composed of units of common sugars, but there is a huge 
interspecies and interstrain variation in the composition and length. In a single LPS 
preparation, the length of the O-antigen may vary from zero to as many as forty repeating 
units, but it generally consists of 20 to 40 repeating units.  Serotype specificity is 
determined by this variability of repeating saccharide units (21).  Each unit is composed  
of three sugars with a single sugar connected to the first and third sugar of the unit. LPS 
molecules with O-antigen are denoted S-LPS. Colonies from bacteria with                     
O-antigen-containing LPS have a smooth (S) appearance on the plate, while bacteria that 
express an O-antigen-lacking LPS have a rough (R) appearance (22).  The LPS from 
several oral anaerobic species also exhibited various chemical compositions (23).  The                   
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Figure 1.1 Diagram Representing the Structure of LPS. 
The diagram represents sugars as hexagons. 
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composition of the O-side chain varies between different Gram-negative bacterial strains.  
O-side chains are easily recognized by the antibodies of the host; however, the nature of 
the chain can easily be modified by Gram-negative bacteria to avoid detection (24).  In 
addition, the optimal immune activating lipid A structure was shown to contain 6 acyl 
chains.  The length of the carbon chains usually varies between C10 and C16, with some 
exceptions.   The lipid A of E.coli typically has five C14 and one C12 (25).  Variations in 
structure result from the type of hexosamine and phosphate substituents present, the 
degree of phosphorylation, and most importantly the nature, chain length, number, and 
location of acyl groups (16).  Therefore, the chemical composition of LPS can be 
modified in order to present a specific sugar structure.   
 
Lynn et al. (26) reported that most of the biological activities of LPS were linked 
to their lipid A portion, which has a structure that is constant among different species, 
compared with the polysaccharide side chains.  LPS and other bacterial (surface) 
components are recognized by complement and antibodies, leading to opsonisation and 
lysis of the bacterium. Phagocytes (monocytes, macrophages, and polymorphonuclear 
leukocytes) are able to recognize opsonized bacterial components by complement 
receptors and Fc receptors that bind immunoglobulin G [IgG] antibodies.  Recognition of 
LPS or other bacterial components by these cells initiates a cascade of release of 
inflammatory mediators, vascular and physiological changes, and recruitment of immune 
cells. An LPS-activated macrophage becomes metabolically active and produces 
intracellular stores of oxygen free radicals and other microbiocidal agents (lysozyme, 
cationic proteins, acid hydrolases, and lactoferrin) and secretes inflammatory mediators.  
After exposure to LPS, TNF-α is one of the first cytokines released by macrophages.  The 
release of TNF-α, IL-1, IL-6, IL-8, IL-12, platelet-activating factor (PAF), chemokines, 
and eicosanoids has profound effects on the surrounding tissue.  The actions of the 
activated immune cells combined with the effects of the inflammatory mediators cause 
symptoms such as fever, endothelial damage, capillary leakage, peripheral vascular 
dilatation, coagulation disorders, microthrombi, and myocardial depression. These 
phenomena may finally result in multiple organ dysfunction, shock, and death (27,28).   
 
 
Secretory Leukocyte Protease Inhibitor 
 
Secretory leukocyte protease inhibitor (SLPI) is produced by secretory cells in 
respiratory, genital and lacrimal glands, and by inflammatory cells that include 
macrophages, neutrophils, and B cells (29).  SLPI is an 11.7 kD (107 amino acid), non-
glycosylated, single-chain serine protease inhibitor (30).  Specifically, SLPI is comprised 
of two homologous cysteine-rich domains of 53 and 54 amino acids.  SLPI inhibits 
several serine proteases.  Examples are elastase and cathepsin G secreted from 
neutrophils, trypsin and chymotyrpsin from pancreatic acinar cells, and chymase and 
tryptase from mast cells (31).  Therefore, a major physiological role of SLPI is 
considered to be the protection of tissue from these proteases at sites of inflammation.  
However, recent studies have demonstrated that SLPI functions as more than just a 
protease inhibitor.  SLPI suppresses bacterial growth, inhibits infection of lymphocytes 
by human immunodeficiency virus-1 (HIV-1), ameliorates bacterial arthritis, and 
 5 
decreases production of PGE2 and matrix metalloproteinases (MMP)-1 and 9 (32,33).  
SLPI is involved in normal cutaneous wound healing, a result previously shown in a 
study on SLPI deficient mice (34).  Moreover, SLPI modifies macrophage function in 
mice, as shown by the fact that ectopic expression of SLPI cDNA in macrophages 
increases their resistance to LPS, and that SLPI suppresses macrophages response to LPS 
(35).  Consistently, serum SLPI levels are elevated in endotoxin shock in humans (36).  
These observations strongly suggest that SLPI is an important participant in innate 
immunity where it acts as an anti-inflammatory molecule.  LPS is among the most potent 
molecular stimuli of the immune system.  SLPI in gingival crevicular fluids has been 
shown to promote the healing of periodontal tissue after clinical treatment for chronic 
periodontitis (37).  P. gingivalis releases cysteine proteinases that digest SLPI, leading to 
inactivation of its functions and may attenuate the host protective response including loss 
of neutralization of neutrophil-derived proteases and susceptible responses to bacterial 
toxins (38). 
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CHAPTER 2. SPECIFIC OBJECTIVES 
 
 
The objective of this investigation was to study the interaction of LPS isolated 
from three periodontal pathogens, P. gingivalis, P. denticola, and F. nucleatum with 
cultured human monocytes. Monocyte ability to secrete SLPI when induced with LPS 
was determined. SLPI has been shown to be secreted by human monocytic cells. In the 
second part of this study, we tested the effect of SLPI on LPS-stimulated secretion of 
inflammatory cytokines by the monocytes, since the SLPI has been shown to suppress the 
production of these cytokines.  
  
This study tested the hypothesis that virulent periodontal pathogens suppress the 
production of inflammatory cytokines initially, by stimulating the monocytes to secrete 
SLPI. Once the SLPI is secreted which in turn suppresses the production of cytokines by 
the monocytes, which will help the pathogens to prevail in the oral cavity and colonize 
successfully, leading to severe periodontitis. Preliminary data from studies demonstrated 
that LPS of periodontal pathogens induced the monocytes to secrete significant amount of 
SLPI. Addition of exogenous SLPI along with LPS, suppressed the levels of secretion of 
inflammatory cytokines. Suppressing the inflammatory cytokines at an initial stage of 
infection by the periodontal pathogens may allow the pathogens to proliferate and survive 
in the host and cause severe periodontal disease. 
 
 
Specific Aim 1: Influence of Periodontal Pathogens on Monocytes to Secrete SLPI 
  
Determine the influence of LPS isolated from periodontal pathogens,                   
P. gingivalis, P. denticola, and F. nucleatum on the cultured human monocytic cells to 
secrete SLPI.  The amount of SLPI secreted will be measured by ELISA. 
 
  
Specific Aim 2: Cytokine Expression by SLPI-Influenced Monocytes 
 
 Evaluate the influence of exogenous SLPI on LPS-induced secretion of 
inflammatory cytokines, IL-1 β and TNF-  by the monocytic cells. The amounts of  
TNF-α and IL-1β produced by the human monocytic cells exposed to LPS + SLPI will be 
measured by ELISA. 
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CHAPTER 3. MATERIALS AND METHODS 
 
 
Materials 
 
The bacteria, P. gingivalis (25260), P. denticola (33185), and F. nucleatum 
(10953), were obtained from ATCC, Rockville, MD.  The bacteria were grown in the 
laboratory under anaerobic conditions in thioglycollate broth at 37 C in an anaerobic jar 
for 72 hours. SLPI was purchased commercially from R&D Systems.  THP-1 cells 
(ATCC TIB202) were obtained from ATCC, Rockville, MD.  Commercial enzyme-
linked immunosorbent assay (ELISA) kits from R&D Systems were employed to 
measure the cytokines TNF-  and IL-1  released by the monocytes.  ELISA kit from 
R&D Systems was also used to measure the SLPI secreted by monocytes.  LPS from     
E. coli was purchased from Sigma.   
 
 
Methods 
 
 
LPS Preparation        
  
Bacteria were grown in one-liter quantities in thioglycollate broth (Difco) for 72 
hours in an anaerobic jar.  The bacteria were harvested by centrifugation and the cell 
pellets were washed with physiological saline, then with de-ionized water and 
centrifuged.  The bacterial cell pellets were lyophilized and the LPS was prepared by the 
hot phenol-water extraction method as described by Westphal and Jann (39).  Batches of 
0.25 g of the lyophilized bacteria were suspended in 200 ml of 90% phenol and water and 
incubated at 67 C for 15 minutes and then stirred for another 15 minutes on a stirrer at 
room temperature.  The mixture was chilled on ice to 10 C to separate the phases.  The 
resultant LPS-containing aqueous phase was then collected from the lower phenol phase.  
The non-aqueous phenol phase was subjected to a second extraction by adding an 
additional 200 ml of water.  The pooled aqueous phase was dialyzed against distilled 
water at 4 C for 48 hours.  The aqueous phase was collected and frozen using liquid 
nitrogen and then lyophilized.  The purity and protein contamination of the isolated LPS 
was confirmed by gel electrophoresis (10% polyacrylamide gel containing 0.1% sodium 
dodecyl sulfate; (40)).  LPS samples were sonicated gently prior to electrophoresis, and 
then the gel was stained with silver nitrate stain. 
 
 
Limulus Amoebocyte Lysate (LAL) Assays 
 
The endotoxin activity of the LPS samples was measured with the Limulus 
amoebocyte assay for LPS or endotoxin (41).  The Limulus endotoxin assay is a test 
developed from the blood cells of the horseshoe crab that detects miniscule amounts of 
endotoxins in fluids.  All assays were conducted in 96-well microplate; a           
computer-controlled Bio-Rad microplate reader was used.  A turbidimetric assay was 
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used, in which the increasing turbidity caused by the gelation of the Limulus lysate in 
response to LPS was followed over time.  Samples were prepared in a volume of 0.2 ml.  
LPS preparations from the following bacteria:  P. denticola, F. nucleatum, and               
P. gingivalis, were prepared at concentrations of 0.1 to 100 ng/ml.  Highly purified LPS 
from E. coli K235 was used to prepare the standards over a concentration range of 0.1  
ng/ml to 10 ng/ml.   E.coli LPS was used as a positive control.  The assay was initiated by 
addition of 50 l of Limulus lystate reagent to each well containing appropriate dilutions 
of LPS.  The samples were read at an absorbance of 450 nm.  Plots were made of the 
absorbance of each sample over time, and the curves were compared with those of the   
E. coli LPS standards.  The activity of each LPS sample in causing gelation of Limulus 
lysate was expressed in units corresponding to the activity of 1 ng/ml of E.coli LPS. 
 
 
 Preparation of Monocytes   
  
 THP-1, originally isolated from a child with acute leukemia, are mature cells in 
the monocyte/macrophage lineage with a normal diploid karyotype, and they produce 
TNF-α and other cytokines in response to purified endotoxin. These non-adherent cells 
were maintained in continuous culture with RPMI 1640 (GIBCO/BRL, Grand Island, 
N.Y.), 10% fetal bovine serum (GIBCO/BRL), and 0.05 mM 2-mercaptoethanol 
(GIBCO/BRL) in an atmosphere of 5% CO2 at 378 C. The doubling time for these cells 
under these conditions is approximately 48 h. THP-1 cells were treated with phorbol    
12-myristate 13-acetate (10
-7
 M; Calbiochem Co., La Jolla, Calif.) to induce maturation 
of the monocytes and became macrophage-like; differentiated macrophages were 
identified by morphological features and their ability to adhere to plastic. Before 
experimentation or treatment with phorbol-12-myristate-13-acetate, THP-1 cells were 
washed three times with culture medium without fetal bovine serum and resuspended to a 
concentration of 1x10
6
 cells per ml. Cell viability was determined to be 95% by the 
trypan blue dye exclusion assay. Different concentrations of bacterial LPS (1,10, and 25 
g/ml) were added and incubated for 72 hours.  Supernatant fluids were collected, 
centrifuged and assayed for the cytokines TNF-  and IL-1  by ELISA.  
  
 
 Cytokine Assay  
  
 Monocytes (THP-1 cells) were prepared as described above.  ELISA kits from 
R&D Systems were employed to measure the concentration of TNF-α and IL-β released 
from the THP-1 cells when stimulated with LPS of P. gingivalis, P. denticola, and         
F. nucleatum. E. coli LPS served as the control. The standard for both assays was 
reconstituted using deionized water producing a stock solution of 10,000 pg/ml, the 
standard was allowed to sit for 15 minutes with gentle agitation prior to making dilutions. 
405 μl of Reagent Diluent consisting of 1% Bovine Serum Albumin (BSA) in Phosphate 
Buffered Solution (PBS), pH 7.2-7.4 was added to 45 μl of the stock solution in a tube to 
produce a standard with a concentration of 1000 pg/ml; this 1000 pg/ml standard serves 
as the high standard.  An assay dilution series was produced by pipiting equal amounts of 
reagent diluent and the standard into the remaining tubes; this produced a dilution series 
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with the following concentrations: 1000 pg/ml, 500 pg/ml, 250 pg/ml, 125 pg/ml, 62.5 
pg/ml, 31.2 pg/ml, and 15.6 pg/ml.  The Reagent Diluent served as the zero standard.  
Enclosed microplate strips were used for all assays, the microplates were coated with a 
mouse monoclonal antibody against human TNF-α or IL-1β depending upon which 
cytokine being measured in an experiment. The first column held the standard dilution 
series and the additional columns held the samples being tested. The concentrations of 
LPS tested for the periodontal pathogens were 1µg/ml to 25 µg/ml. 50 μl of Assay 
Diluent was added to each well followed by 200 μl of standard, control, or sample; this 
was incubated at room temperature for 2 hours.  Following incubation, each well was 
aspirated and washed 4 times with wash buffer; the wash buffer consisted of 0.05% 
Tween 20 in PBS.  An aliquot (200 μl) of conjugate consisting of a polyclonal antibody 
against human TNF-α or IL-1β, depending upon the cytokine being measured,  
conjugated to horseradish peroxidase was added to each well and incubated at room 
temperature for 1 hour.  The aspiration step was repeated and 200 μl of substrate solution 
was added to each well and incubated at room temperature for 20 minutes.  To stop the 
reaction, 50 μl of stop solution was added to each well and the microplates were read at 
450 nm.   
 
 
 SLPI Assay 
  
 Monocytes (THP-1 cells) were prepared as previously described.  ELISA kits 
from R&D Systems were employed to measure the concentration of SLPI released from 
the THP-1 cells when stimulated with LPS of P. gingivalis, P. denticola, and                  
F. nucleatum. E. coli served as the control.  The concentrations of LPS for the 
periodontal pathogens tested were 1µg/ml to 25µg/ml. The standard for the assay was 
reconstituted using calibrator diluent producing a stock solution of 4,000 pg/ml, the 
standard was allowed to sit for 15 minutes with gentle agitation prior to making dilutions. 
100 μl of Reagent Diluent consisting of 1% Bovine Serum Albumin (BSA) in Phosphate 
Buffered Solution (PBS), pH 7.2-7.4 was added to 100 μl of the stock solution in a tube 
to produce a standard with a concentration of 2,000 pg/ml; this 2,000 pg/ml standard 
serves as the high standard.  An assay dilution series was produced by pipitting equal 
amounts of reagent diluent and the standard into the remaining tubes; this produced a 
dilution series with the following concentrations: 1000 pg/ml, 500 pg/ml, 250 pg/ml, 125 
pg/ml, and 62.5 pg/ml.  The Reagent Diluent served as the zero standard.  Enclosed 
microplate strips were used for all assays, the microplates were coated with a mouse 
monoclonal antibody against human SLPI. The first column held the standard dilution 
series and the additional columns held the samples being tested.  100 μl of Assay Diluent 
was added to each well followed by 100 μl of standard, control, or sample; this was 
incubated at room temperature for 2 hours.  Following incubation, each well was 
aspirated and washed 4 times with wash buffer; the wash buffer consisted of 0.05% 
Tween 20 in PBS.  An aliquot (200 μl) of conjugate consisting of a polyclonal antibody 
against human SLPI conjugated to horseradish peroxidase was added to each well and 
incubated at room temperature for 1 hour.  The aspiration step was repeated and 200 μl of 
substrate solution was added to each well and incubated at room temperature for 20 
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minutes.  50 μl of stop solution was added to each well and the microplates were read at 
450 nm.   
 
  
 Cytokine Assay Combined with Exogenous SLPI 
 
 Monocytes (THP-1 cells) were prepared as described above.  ELISA kits from 
R&D Systems were employed to measure the concentration of TNF-α and IL-β released 
from the THP-1 cells when stimulated with LPS of P. gingivalis, P. denticola, and         
F. nucleatum. E. coli LPS served as the control. The standard for both assays was 
reconstituted using deionized water producing a stock solution of 10,000 pg/ml, the 
standard was allowed to sit for 15 minutes with gentle agitation prior to making dilutions. 
405 μl of Reagent Diluent consisting of 1% Bovine Serum Albumin (BSA) in Phosphate 
Buffered Solution (PBS), pH 7.2-7.4 was added to 45 μl of the stock solution in a tube to 
produce a standard with a concentration of 1000 pg/ml; this 1000 pg/ml standard serves 
as the high standard.  An assay dilution series was produced by pipiting equal amounts of 
reagent diluent and the standard into the remaining tubes; this produced a dilution series 
with the following concentrations: 1000 pg/ml, 500 pg/ml, 250 pg/ml, 125 pg/ml, 62.5 
pg/ml, 31.2 pg/ml, and 15.6 pg/ml.  The Reagent Diluent served as the zero standard.  
Enclosed microplate strips were used for all assays, the microplates were coated with a 
mouse monoclonal antibody against human TNF-α or IL-1β depending upon which 
cytokine being measured in an experiment. The first column held the standard dilution 
series and the additional columns held the samples being tested. The concentrations of 
LPS tested for the periodontal pathogens were 1µg/ml to 10 µg/ml. Exogenous SLPI at a 
concentration of 1µg/ml to 10 µg/ml was added at the same time to the LPS being tested.  
50 μl of Assay Diluent was added to each well followed by 200 μl of standard, control, or 
sample; this was incubated at room temperature for 2 hours.  Following incubation, each 
well was aspirated and washed 4 times with wash buffer; the wash buffer consisted of 
0.05% Tween 20 in PBS.  An aliquot (200 μl) of conjugate consisting of a polyclonal 
antibody against human TNF-α or IL-1β, depending upon the cytokine being measured,  
conjugated to horseradish peroxidase was added to each well and incubated at room 
temperature for 1 hour.  The aspiration step was repeated and 200 μl of substrate solution 
was added to each well and incubated at room temperature for 20 minutes.  To stop the 
reaction, 50 μl of stop solution was added to each well and the microplates were read at 
450 nm.   
 
 
Data Analysis 
 
 Each experiment was performed at least two times using triplicate samples.  Mean 
values ± SEM from triplicate samples were calculated and the significance of differences 
was assessed using a two-tailed Student’s t-test.  Differences in results with a p-value< 
0.05 were considered significant. 
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CHAPTER 4. RESULTS 
 
 
Limulus Activity 
  
 The endotoxin activities of isolated LPS from periodontal pathogens were 
measured first with the Limulus assay (41).  Stock solutions of LPS preparations from    
E. coli, Aa, F. nucleatum, P. gingivalis, and P. denticola were prepared in sterile water at 
10ng/ml.  These solutions were placed in an ultrasonic bath for 20 seconds before use to 
ensure an uniform suspension.  Samples of these LPS solutions were then tested for 
Endotoxin activity by their ability to cause gelation of Limulus amebocyte lysate over a 
period of 60 minutes.  This is a standard measure of LPS or Endotoxin activity.  The 
Limulus assay uses a homogenate or lystate made from the macrophage-like amebocytes 
taken from the blue blood (hemolymph) of the horseshoe crab (Limulus polyphemus).  
This lysate gels and becomes turbid in the presence of LPS and the turbidity was 
measured at 450nm.  This method has a high degree of sensitivity and can detect 0.001 to 
100ng/ml LPS.  As a standard we have used E. coli LPS.  The activity of each LPS 
sample in causing gelation of Limulus lysate was expressed in units corresponding to the 
activity of 1ng/ml of E. coli LPS.  The results (Figure 4.1) show that all four LPS 
preparations demonstrated measurable Endotoxin activity.  The Endotoxin activity of Aa, 
F. nucleatum, and P. gingivalis, were almost identical, while the activity of P. denticola 
was slightly lower.  The LPS activity of periodontal pathogens both had about one-third 
activity of the highly purified E. coli LPS standard. 
 
 
Influence of Periodontal Pathogens on Monocytes to Secrete SLPI and Cytokines 
  
 The goal of these experiments was to determine whether SLPI is induced by 
monocytes in response to stimulation by the LPS of periodontal pathogens and to 
determine if there are any differences in the rate of secretion of SLPI by macrophages.  
The amount of SLPI secreted by the three periodontal pathogens selected was also 
compared.  Isolated LPS from P.gingivalis, P. denticola, and F. nucleatum was added to 
the cultured monocytes and the supernatants were assayed for the secreted inflammatory 
cytokines, TNF-α, IL-1β, and SLPI by ELISA.  E. coli LPS served as the control.   
 
 
TNF-α Secretion by THP-1 Cells in Response to LPS of Periodontal Pathogens 
  
 TNF-α is a cytokine involved in systemic inflammation and is a member of a 
group of cytokines that stimulate the acute phase reaction. The primary role of TNF-  is 
in the regulation of immune cells. TNF-  was found to induce apoptotic cell death and 
inflammation, and to inhibit tumorigenesis and viral replication.   
  
The goals of these experiments were to determine whether the isolated LPS from 
the periodontal pathogens would stimulate the THP-1 cells to secrete the inflammatory 
cytokine TNF-  and to quantify the amount of TNF-  secreted by the THP-1 cells.  The 
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Figure 4.1 Endotoxin Activity of LPS Preparations from E. coli and Oral Pathogens 
at 10 ng/ml. 
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ELISA assay from R&D Systems was employed to measure the concentration of TNF-  
released from the THP-1 cells when stimulated with the LPS of P. gingivalis,                 
P. denticola, and F. nucleatum.  Cultured monocytes were incubated with 1 g/ml, 10 
g/ml, and 25 g/ml of LPS isolated for each periodontal pathogen.   
 
Figure 4.2 shows the secretion of TNF-α by the monocytes to be dose-dependent 
upon the concentration of the LPS.  The higher the concentration of LPS caused more 
TNF-α to be secreted by the monocytes.  The monocytes treated with THP cells alone 
secreted 13 pg/ml of TNF- , when the monocytes were treated with the LPS of              
P. gingivalis at a concentration of 1 g/ml  the amount of TNF-α secreted was 137.6 
pg/ml when the concentration increased to 25 g/ml the amount of  TNF-α secreted 
increased to 1093 pg/ml  The data also showed the more pathogenic bacterial LPS from 
P. gingivalis and P. denticola caused a significantly (p<0.05) higher amount of TNF-α to 
be secreted by the monocytes than  F. nucleatum.  The cells treated with a concentration 
of 25 g/ml of LPS from P. denticola secreted 1326 pg/ml of TNF-α while the same 
concentration of F. nucleatum lead to only 387 pg/ml of TNF-α secretion.  However, 
there were no differences in the ability of P. gingivalis and P. denticola LPS to stimulate 
THP-1 cells. 
 
 
IL-1β Secretion by THP-1 Cells in Response to LPS of Periodontal Pathogens 
 
 IL-1β is a pro-inflammatory cytokine involved in immune defense against 
infection.  IL-1β is produced by macrophages, monocytes and dendritic cells.  IL-1β 
increases the expression of adhesion factors on endothelial cells to enable transmigration 
of leukocytes to the area of infection.   
  
The aim of these experiments were to determine whether the LPS isolated from 
the periodontal pathogens would encourage the THP-1 cells to secrete the pro-
inflammatory cytokine IL-1β and to quantify the amount of IL-1β secreted by the THP-1 
cells.  The ELISA assay from R&D Systems was used to measure the concentration of 
IL-1β released from the THP-1 cells when stimulated with the LPS of P. gingivalis,                 
P. denticola, and F. nucleatum.  Cultured monocytes were incubated with 1 µg/ml, 10 
µg/ml, and 25 µg/ml of LPS for each periodontal pathogen.   
  
Figure 4.3 shows the secretion of IL-1β by the monocytes to be dose-dependent 
upon the concentration of the LPS.  Higher concentrations of LPS lead to higher amounts 
of IL-1β to be secreted by the monocytes.  The monocytes treated with THP cells alone 
secreted 11.7 pg/ml of IL-1β, when the monocytes were treated with the LPS of             
P. gingivalis at a concentration of 1 g/ml  the amount of IL-1β secreted was 93 pg/ml 
when the concentration increased to 25 g/ml the amount of IL-1β secreted increased to 
782 pg/ml  The data showed the more virulent bacterial LPS from P. gingivalis and        
P. denticola caused a higher amount of IL-1β to be secreted by the monocytes than             
F. nucleatum.  The cells treated with a concentration of 25 g/ml of LPS from                
P. denticola secreted 1026 pg/ml of IL-1β while the same concentration of F. nucleatum 
lead to only 282 pg/ml of IL-1β secretion. 
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Figure 4.2 Demonstration of TNF-α Secretion by Cultured THP Cells in Response to 
LPS of Periodontal Pathogens.   
The differences in stimulation by Pg and Pd LPS at all concentrations tested was found to 
be significantly higher than by Fn LPS (p<0.05).  The results are the means ± the 
standard error, N=3 run in triplicate. 
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Figure 4.3 Demonstration of IL-1β Secretion by Cultured THP Cells in Response to 
LPS of Periodontal Pathogens.   
Pg and Pd LPS at a concentration of 10 µg/ml stimulated secretion of IL-1β at 
significantly higher (p<0.005) quantities than 25 µg/ml of Fn LPS.  The results are the 
means ± the standard error, N=3 run in triplicate. 
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SLPI Secretion by THP-1 Cells in Response to LPS of Periodontal Pathogens 
  
 SLPI was shown to be involved in the protection of epithelial tissues from serine 
proteases. It is found in various secretions including seminal plasma, cervical mucus, and 
bronchial secretions, and has affinity for trypsin, leukocyte elastase, and cathepsin G. Its 
inhibitory effect contributes to the immune response by protecting epithelial surfaces 
from attack by endogenous proteolytic enzymes. 
  
The aim of these experiments was to determine whether the LPS isolated from the 
periodontal pathogens would stimulate the THP-1 cells to secrete the protease inhibitor, 
SLPI.  The ELISA assay from R&D Systems was used to measure the concentration of 
SLPI released from the THP-1 cells when stimulated with the LPS of   P. gingivalis, P. 
denticola, and F. nucleatum.  LPS concentrations of 1µg/ml, 10 µg/ml, and 25 µg/ml for 
each periodontal pathogen were tested, E. coli LPS served as a control. 
  
Figure 4.4 demonstrates the secretion of SLPI by the monocytes to be            
dose-dependent upon the concentration of the LPS.  Higher concentrations of LPS lead to 
higher amounts of SLPI to be secreted by the monocytes.  The monocytes treated with 
THP cells alone secreted 12 pg/ml of SLPI, when the monocytes were treated with the 
LPS of P. gingivalis at a concentration of 1 g/ml  the amount of SLPI secreted was 128 
pg/ml when the concentration increased to 25 g/ml the amount of SLPI secreted 
increased to 876 pg/ml.  The data showed the more virulent bacterial LPS from              
P. gingivalis and P. denticola stimulated THP cells to secrete greater amounts of SLPI 
than F. nucleatum or E. coli LPS. The cells treated with a concentration of 25 g/ml of 
LPS from P. denticola secreted 943 pg/ml of SLPI while the same concentration of        
F. nucleatum and E. coli lead to only 496 pg/ml and 118 pg/ml of SLPI secretion, 
respectively. 
 
 
Effect of Exogenous SLPI on THP-1 Cells Stimulated with LPS of Pg on the 
Secretion of IL-1β and TNF-α 
 
Figure 4.5 demonstrates the secretion of IL-1β by the monocytes when treated 
with P. gingivalis to be dose-dependent as previously described with concentrations of 1 
µg/ml and 10 µg/ml.  However, when exogenous SLPI (1-10 µg/ml) was added to the 
cells, the amount of IL-1β secreted by the monocytes decreased significantly (p<0.05).  
Monocytes treated with P. gingivalis (10 µg/ml) LPS + SLPI (1 µg/ml) secreted 414 
pg/ml of IL-1β, while monocytes treated with P. gingivalis (10 µg/ml) LPS + SLPI (10 
µg/ml) secreted 135 pg/ml of IL-1β. 
  
 Figure 4.6 demonstrates the secretion of TNF-α by the monocytes when treated 
with P. gingivalis to be dose-dependent as previously described with concentrations of 1 
µg/ml and 10 µg/ml.  However, when exogenous SLPI (1-10 µg/ml) was added to the 
cells, the amount of TNF-α secreted by the monocytes decreased significantly (p<0.05).  
Monocytes treated with P. gingivalis (10 µg/ml) LPS + SLPI (1 µg/ml) secreted 398 
pg/ml of TNF-α, while monocytes treated with P. gingivalis (10 µg/ml) LPS + SLPI (10 
 17 
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Figure 4.4 Demonstration of SLPI Secretion by Cultured THP Cells in Response to 
LPS of Periodontal Pathogens. 
At 1 µg/ml LPS concentration of Pg and Pd the ability to stimulate secretion of SLPI was 
significantly different (p<0.05) from Fn and theE. coli LPS control.  No significant 
difference was seen between Pg and Pd LPS (25 µg/ml).  The results are the means ± the 
standard error, N=3 run in triplicate. 
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Figure 4.5 Effect of Exogenous SLPI on Cultured THP Cells Stimulated with LPS of 
P. gingivalis on the Secretion of IL-1β.   
The results are the means ± the standard error, N=3 run in triplicate. 
 
 
 19 
 
 
 
 
P
g
 L
P
S
 (
1
u
g
/m
l)
P
g
 L
P
S
 (
1
u
g
/m
l)
+
S
L
P
I 
(1
u
g
/m
l)
P
g
 L
P
S
 (
1
u
g
/m
l)
+
S
L
P
I 
(1
0
u
g
/m
l)
P
g
 L
P
S
 (
1
0
u
g
/m
l)
P
g
 L
P
S
 (
1
0
u
g
/m
l)
+
S
L
P
I 
(1
u
g
/m
l)
P
g
 L
P
S
 (
1
0
u
g
/m
l)
+
S
L
P
I 
(1
0
u
g
/m
l)
0
100
200
300
400
500
600
700
p
g
/m
l 
T
N
F
-a
lp
h
a
 s
ec
re
te
d
LPS tested
 
 
Figure 4.6 Effect of Exogenous SLPI on Cultured THP Cells Stimulated with LPS of 
P. gingivalis on the Secretion of TNF-α.  The results are the means ± the standard error, 
N=3 run in triplicate. 
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µg/ml) secreted 106 pg/ml of TNF-α. 
 
 
Effect of Exogenous SLPI on THP-1 Cells Stimulated with LPS of Pd on the 
Secretion of IL-1β and TNF-α 
  
 Figure 4.7 demonstrates the secretion of IL-1β by the monocytes when treated 
with P. denticola to be dose-dependent as previously described with concentrations of 
1µg/ml and 10µg/ml.  However, when exogenous SLPI (1-10 µg/ml) was added to the 
cells, the amount of IL-1β secreted by the monocytes decreased significantly (p<0.05).  
Monocytes treated with P. denticola (10 µg/ml) LPS + SLPI (1 µg/ml) secreted 323 
pg/ml of IL-1 β, while monocytes treated with P. denticola (10 µg/ml) LPS + SLPI (10 
µg/ml) secreted 102 pg/ml of IL-1β. 
 
 Figure 4.8 demonstrates the secretion of TNF-α by the monocytes when treated 
with P. denticola to be dose-dependent as previously described with concentrations of 
1µg/ml and 10µg/ml.  However, when exogenous SLPI (1-10 µg/ml) was added to the 
cells, the amount of TNF-α secreted by the monocytes decreased significantly (p<0.05). 
Monocytes treated with P. denticola (10 µg/ml) LPS + SLPI (1 µg/ml) secreted 406 
pg/ml of TNF-α, while monocytes treated with P. denticola (10 µg/ml) LPS + SLPI (10 
µg/ml) secreted 118 pg/ml of TNF-α. 
 
 
Effect of Exogenous SLPI on THP-1 Cells Stimulated with LPS of Fn on the 
Secretion of IL-1β and TNF-α 
 
 Figure 4.9 demonstrates the secretion of IL-1β by the monocytes when treated 
with F. nucleatum to be dose-dependent as previously described with concentrations of 
1µg/ml and 10µg/ml.  However, when exogenous SLPI (1-10 µg/ml) was added to the 
cells, the amount of IL-1β secreted by the monocytes decreased significantly (p<0.05).  
Monocytes treated with F. nucleatum (10 µg/ml) LPS + SLPI (1 µg/ml) secreted 105 
pg/ml of IL-1β, while monocytes treated with F. nucleatum (10 µg/ml) LPS + SLPI (10 
µg/ml) secreted 51 pg/ml of IL-1β. 
 
Figure 4.10 demonstrates the secretion of TNF-α by the monocytes when treated 
with F. nucleatum to be dose-dependent as previously described with concentrations of 
1µg/ml and 10µg/ml.  However, when exogenous SLPI (1-10 µg/ml) was added to the 
cells, the amount of TNF-α secreted by the monocytes decreased significantly (p<0.05).  
Monocytes treated with F. nucleatum (10 µg/ml) LPS + SLPI (1 µg/ml) secreted 150 
pg/ml of TNF-α, while monocytes treated with F. nucleatum (10 µg/ml) LPS + SLPI (10 
µg/ml) secreted 43 pg/ml of TNF-α. 
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Figure 4.7 Effect of Exogenous SLPI on Cultured THP Cells Stimulated with LPS of 
P. denticola on the Secretion of IL-1β. 
The results are the means ± the standard error, N=3 run in triplicate. 
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Figure 4.8 Effect of Exogenous SLPI on Cultured THP Cells Stimulated with LPS of 
P. denticola on the Secretion of TNF-α. 
The results are the means ± the standard error, N=3 run in triplicate. 
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Figure 4.9 Effect of Exogenous SLPI on Cultured THP Cells Stimulated with LPS of 
F. nucleatum on the Secretion of IL-1β. 
The results are the means ± the standard error, N=3 run in triplicate. 
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Figure 4.10 Effect of Exogenous SLPI on Cultured THP Cells Stimulated with LPS 
of F. nucleatum on the Secretion of TNF-α. 
The results are the means ± the standard error, N=3 run in triplicate. 
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Effect of Exogenous SLPI on THP-1 Cells Stimulated with LPS of Ec on the 
Secretion of IL-1β and TNF-α 
 
Figure 4.11 demonstrates the secretion of IL-1β by the monocytes when treated 
with E. coli to be dose-dependent as previously described with concentrations of 1µg/ml 
and 10µg/ml.  However, when exogenous SLPI with a concentration of 1µg/ml or 
10µg/ml was added to the cells, the amount of IL-1β secreted by the monocytes 
decreased significantly (p<0.05).  Monocytes treated with E. coli (10 µg/ml) LPS + SLPI 
(1 µg/ml) secreted 84 pg/ml of IL-1β, while monocytes treated with E. coli (10 µg/ml) 
LPS + SLPI (10 µg/ml) secreted 29 pg/ml of IL-1β.   
  
 Figure 4.12 demonstrates the secretion of TNF-α by the monocytes when treated 
with E. coli to be dose-dependent as previously described with concentrations of 1µg/ml 
and 10 µg/ml.  However, when exogenous SLPI with a concentration of 1µg/ml or 10 
µg/ml was added to the cells, the amount of TNF-α secreted by the monocytes decreased 
significantly (p<0.05).  Monocytes treated with E. coli (10 µg/ml) LPS + SLPI (1 µg/ml) 
secreted 137 pg/ml of TNF-α, while monocytes treated with E. coli (10 µg/ml) LPS + 
SLPI (10 µg/ml) secreted 38 pg/ml of TNF-α. 
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Figure 4.11 Effect of Exogenous SLPI on Cultured THP Cells Stimulated with LPS 
of E. coli on the Secretion of IL-1β. 
The results are the means ± the standard error, N=3 run in triplicate. 
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Figure 4.12 Effect of Exogenous SLPI on Cultured THP Cells Stimulated with LPS 
of E. coli on the Secretion of TNF-α. 
The results are the means ± the standard error, N=3 run in triplicate. 
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CHAPTER 5. DISCUSSION 
 
 
 This study demonstrated differences in the biological functions of LPS molecule 
isolated from representative oral bacteria that were shown to be associated with 
periodontal disease.  LPS from three periodontal pathogens, P. gingivalis, P. denticola, 
and F. nucleatum was isolated under identical conditions for this study in order to 
minimize the variations in LPS isolation.  All LPS samples were found to be fairly pure, 
free of protein contamination when analyzed by SDS-gel electrophoresis, with molecular 
weights of approximately 10,000 daltons similar to the previously published studies (40).   
  
The three LPS samples demonstrated very similar endotoxin activity when tested 
with the Limulus assay.  The results showed that the LPS endotoxin activity of 
periodontal pathogens had lower endotoxin activity than the LPS of E. coli.  It required at 
least 3-fold greater amount of LPS of periodontal pathogens to reach the level of activity 
attained by the LPS of E.coli.  Studies have shown the variation in endotoxin activity of 
LPS was attributed to the lipid A structure, which seems to vary among certain bacteria 
(16).  
 
The study demonstrated the interaction of LPS isolated from P. gingivalis,          
P. denticola, and F. nucleatum with cultured human monocytes.  Neutrophils and 
monocytes are the most abundant leukocytes in circulating blood, representing greater 
than 50% of the cells.  They are the first line of cellular defense against infection.  
Monocytes are attracted to a foci of infection and differentiate into macrophages, at this 
point the monocyte function to be either phagocytic or antigen-processing cells (14).  
Monocytes also produce substances called cytokines that are involved in perpetuation of 
inflammation and result in tissue destruction.  Monocytes produce cytokines such as,    
IL-1  and TNF-  cytokines that exert inflammatory effects on target cells in the host 
(15).   
 
 
TNF-α Secretion by THP-1 Cells in Response to LPS of Periodontal Pathogens 
 
 The results of this investigation, demonstrate unique differences among  the LPS 
of tested periodontal pathogens to stimulate TNF-α secretion from the monocytes.  The 
results showed an identical concentration of LPS from P. gingivalis and P. denticola 
induced the monocytes to secrete approximately 4-times more TNF-α than that of          
F. nucleatum.  The results suggest the LPS of P. gingivalis and P. denticola are more 
potent stimulators than the F. nucleatum LPS.  It is possible the LPS of P. gingivalis and                
P. denticola may have a greater binding affinity to the active sites of the monocytes than 
the less pathogenic F. nucleatum.  Thus, it is conceivable that a higher concentration of 
F. nucleatum was needed to attain the same degree of monocyte secretion achieved by   
P. gingivalis and P. denticola.  Studies by Hamada et al (23) have demonstrated the LPS 
of gram-negative bacteria do differ structurally and functionally, and the bacteria can 
modify their structure to elude the host’s immune defenses, this may explain the reason 
why P. gingivalis and P. denticola LPS behaved differently than F. nucleatum.   
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 The results showed the secretion of TNF-α by the monocytes to be                 
dose-dependent, with the higher concentration of LPS of the tested periodontal pathogens 
stimulating the monocytes to secrete higher amounts of TNF-α.  The results suggest the 
TNF-α mediated signals can cross-talk with both the signal transduction pathways 
dependent on a high-affinity LPS receptor CD14 (42) and low-affinity LPS receptors, 
CD11c/CD18 and p73 (43).  Thus, it is possible that a dose-dependent secretion of    
TNF-α by the monocytes was elicited.   
 
 
IL-1β Secretion by THP-1 Cells in Response to LPS of Periodontal Pathogens 
 
 The results of the study, demonstrate variations among the LPS of tested 
periodontal pathogens to stimulate IL-1β secretion from the monocytes.  The results 
showed that the same concentration of LPS from P. gingivalis and P. denticola 
stimulated the monocytes to secrete approximately 3-times more TNF-α than that of      
F. nucleatum.   This data indicated that the LPS of P. gingivalis and P. denticola are 
better stimulated than the F. nucleatum LPS.  One possibility for this finding is the 
monocytes’s binding affinity at their receptor sites may be higher for P. gingivalis and      
P. denticola than for F. nucleatum.  It may be concluded that a greater concentration of 
the less pathogenic F. nucleatum would be required to attain a similar degree of 
monocyte secretion of IL-1β compared to P. gingivalis and P. denticola.  It has been 
demonstrated that the LPS of gram-negative bacteria differ structurally and functionally, 
and this difference in structure may aid the bacteria to evade the immune response (23). 
 
 The results demonstrated a dose-dependent secretion of IL-1β by the monocytes, 
with greater concentrations of LPS from the periodontal pathogens stimulating the 
monocytes to secrete higher amounts of IL-1β.  This finding may suggest that the IL-1β 
mediated signals can cross-talk signal transduction pathways dependent upon high-
affinity LPS receptor CD14 and low-affinity LPS receptors CD11c/CD18 (43).  This may 
contribute to the LPS dose-dependent secretion of IL-1β by the monocytes. 
 
 
SLPI Secretion by THP-1 Cells in Response to LPS of Periodontal Pathogens 
 
 Human SLPI is a potent inhibitor of the serine proteases trypsin, chymotrypsin, 
elastase, cathepsin G, chymase, and tryptase.  Its only known function has been the 
protection of mucosal surfaces from degradation by proteases during inflammation (44), 
although human SLPI also displays broad-spectrum bactericidal activity (45).   
 
 Our results indicated that the LPS of the three periodontal pathogens tested 
induced monocytes to secrete significant amounts of SLPI.  The data indicated that the 
same concentration of LPS from P. gingivalis and P. denticola stimulated the monocytes 
to secrete approximately twice the amount of SLPI than that of F. nucleatum.  This data 
indicates that the LPS of P. gingivalis and P. denticola are more potent stimulators of 
monocytes to produce SLPI than F. nucleatum.  It is possible the LPS of P. gingivalis and                
P. denticola may have a greater binding affinity to the active sites of the monocytes than 
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the less pathogenic F. nucleatum.  Mouse SLPI shares considerable structural homology 
with human SLPI but bears a variant residue at the active site (46).  It has been previously 
established that SLPI expression in murine macrophages is induced by LPS and 
suppressed by gamma interferon (IFN- ) and that SLPI antagonizes LPS-induced 
signaling and secretion (37).  Thus, it is conceivable that a higher concentration of         
F. nucleatum was needed to attain the same degree of monocyte secretion achieved by   
P. gingivalis and P. denticola. 
 
 
Effect of Exogenous SLPI on Cultured THP-1 Cells Stimulated with LPS of                    
Pg, Pd, and Fn on the Secretion of IL-1β and TNF-α 
  
 The results of the study demonstrated an inhibitory effect by SLPI on the       
LPS-induced monocyte’s ability to secrete the inflammatory cytokines TNF-  and IL-1 .  
In the experiments the addition of SLPI at a concentration of 1 g/ml resulted in 
detectable inhibition while at a concentration of 10 g/ml a dramatic suppression of  
TNF-  and IL-1  was observed.  Inhibition of LPS responses may be a consequence of 
SLPI’s antiprotease action.  This hypothesis is consistent with the findings that serine 
protease inhibitor diisopropylfluorophosphate blocked LPS-induced proliferation of B 
cells, while trypsin partially normalized this response in B cells (47).   
 
 Alternatively, SLPI’s action as an LPS inhibitor may be independent of its 
antiproteolytic function.  Plasminogen activator inhibitor (PAI-1), another serine protease 
inhibitor, blocked cell migration by nonproteolytically displacing cells’ integrins from 
their attachment to vitronectin in the extracellular matrix (48).  Integrins can influence 
macrophage responsiveness to LPS and can serve as cofactors for macrophage activation 
by other agents (49).  The inhibitory effect of SLPI on LPS-inducted secretion of IL-1β 
and TNF-α is likely to reflect interference with early steps of signaling.  NF-κB binding 
sites serve as LPS-response elements in the promoters of many LPS-inducible genes, 
including the two products monitored in this experiment.  Activation of this transcription 
factor was reported to be essential for LPS-induced synthesis of many inflammatory 
mediators, including   TNF- , Il-1, IL-2, and IL-6 (38, 50).  SLPI may function by 
engaging a membrane receptor to induce an LPS-antagonistic signal.  SLPI’s three-
dimensional structure suggests that it belongs to a protein family populated largely by 
neurotoxins that share equivalently placed loops held together by four similarly 
positioned disulfide bonds (51).  Where studied, these functionally divergent proteins all 
act by specific binding to membrane receptors.  That SLPI may bind to macrophages is 
consonant with the view that salivary SLPI blocks infectivity of HIV by first binding to 
monocytes (52).  Therefore, it may be concluded that SLPI can act intracellularly to block 
monocyte activation by LPS and inhibit the secretion of IL-1  and TNF- . However, the 
exact mechanism is not clearly understood at this time.    
 
 The results of this study clearly demonstrated that LPS of periodontal pathogens 
differ in their ability to stimulate THP-1 cells to secrete inflammatory cytokines.  LPS of 
pathogenic strains appears to induce secretion of greater amounts of cytokines than the 
less pathogenic organisms.  LPS isolated from pathogenic organisms tested also induced 
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the cultured THP-1 cells to secrete SLPI.  In the presence of exogenous SLPI, the 
amounts of inflammatory cytokines secreted by THP cells in response to LPS appeared to 
be diminished, compared to the stimulation with LPS alone.   
 
 SLPI plays important roles in maintenance of balanced functioning of the host 
immune system.  Although P.gingivalis is the most widely studied periodontopathic 
bacterium contributing to gingival inflammation, recent studies have suggested that        
P. gingivalis is also involved in inflammation in aortas, coronary vessels, and 
atherosclerotic plaques (53, 54).  Therefore, the ability of pathogenic periodontal 
pathogens to avoid detection by the host immune cells by virtue of their ability stimulate 
cells to secrete SLPI.  The SLPI in turn suppresses the secretion of inflammatory 
cytokines.  These factors, taken together may aid in bacterial pathogenicity in the oral 
cavity leading to periodontal disease.  In addition, further studies would be required to 
investigate the potential of SLPI to modulate the disease process. 
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